Guided Therapeutics Inc’s Q3 2026 10-Q window runs Nov 10, 2026 to Nov 17, 2026.
Based on 8 prior 10-Q filings.
Guided Therapeutics Inc · CIK 924515 · Engraved from SEC EDGAR